Abstract
New cervical cancer screening guidelines: was the annual pap too much of a good thing?
Highlights
Fifty years ago in the United States, the leading cause of cancer death among women was cervical carcinoma
New cervical cancer guidelines were released by the United States Preventative Services Task Force (USPSTF) on March 14, 2012
Patients with atypical squamous cells of undetermined significance (ASCUS) on cytology with negative human papillomavirus (HPV) status should be managed the same way as patients with negative cytology
Summary
New Cervical Cancer Screening Guidelines: Was the Annual Pap Too Much of a Good Thing?. Fifty years ago in the United States, the leading cause of cancer death among women was cervical carcinoma. With the advent of the Papanicolaou (Pap) test in 1945, mortality from this malignancy declined more than 70% (Datta et al, 2008; Spitzer, 2007). An annual Pap smear was the recommended guideline for many years. New cervical cancer guidelines were released by the United States Preventative Services Task Force (USPSTF) on March 14, 2012
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
